Recent News

521 News Items found
Pictured: Scott Lowe
In the Lab
In taking a new approach to finding treatments for hepatocellular carcinoma, MSK scientists have uncovered a potential drug target for this highly aggressive cancer.
Pictured: Experimental Brain Tumor
In the Lab
Researchers have engineered a gene into therapeutic cells that allows them to turn off tumor growth if some of the cells become cancerous.
Pictured: 2014 SURP Students
Learn about the experiences and accomplishments of the 2014 Gerstner Sloan Kettering Summer Undergraduate Research Program students during their ten-week course of study.
Stained pathology slides of a patient’s tumor (right) and of an organoid made from that tumor (left).
In the Lab
Researchers have created tiny structures called organoids from patients’ prostate tumors. These organoids will allow the study of tumors in greater detail and enable correlation of genetic mutations with drug response.
Pictured: Johanna Joyce
In the Lab
A new study sheds light on what enables breast cancer cells to spread to the brain and presents a potential target for drugs.
Pictured: Jessica Rios-Esteves
Gerstner Sloan Kettering student Jessica Rios-Esteves has been awarded the Chairman’s Prize for her first-author paper published in Cell Reports in 2013.
Lab mouse with cultured human pluripotent stem cells
In the Lab
Memorial Sloan Kettering researchers have developed a powerful new way to study human disease using stem cells whose genomes can be manipulated at will.
An origami crane illustrates the importance of RNA folding for regulating gene translation. The bolded sequences on the crane’s wings indicate the portion that is critical for the manufacture of many cancer-causing proteins.
In the Lab
Memorial Sloan Kettering researchers have found a naturally occurring compound that can destroy cancer cells in mice by targeting <em>MYC</em>, a cancer-causing gene that has remained elusive until now.
Pictured: Gabriela Chiosis
Finding
A small molecule discovered at MSK called PU-H71 blocks the growth of cancer cells and enables doctors to image tumors.
Memorial Sloan Kettering is transforming our understanding and treatment of cancer in a myriad of ways.
Feature
Memorial Sloan Kettering’s vision is nothing less than to revolutionize the treatment of cancer. Learn about some of the ways we’re doing it.